Table 2.
Amyloid-β | Metabolism | Volume | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
EMCI | LMCI | AD | EMCI | LMCI | AD | EMCI | LMCI | AD | ||
Clustering coefficient | CN | 0.167 | 0.999 | 0.178 | 0.323 | 0.021 | 0.718 | 0.009 | 0.977 | 0.999 |
EMCI | 0.183 | <0.001 | 0.630 | 0.031 | 0.030 | 0.012 | ||||
LMCI | 0.162 | <0.001 | 0.990 | |||||||
Path length | CN | 0.264 | <0.001 | 0.630 | 0.015 | 0.001 | 0.357 | 0.106 | 0.664 | 0.005 |
EMCI | 0.189 | 0.922 | 0.884 | <0.001 | 0.667 | <0.001 | ||||
LMCI | 0.044 | <0.001 | <0.001 | |||||||
Small-world coefficient | CN | 0.101 | 0.940 | 0.301 | 0.184 | 0.002 | 0.701 | 0.011 | 0.967 | 0.987 |
EMCI | 0.313 | <0.001 | 0.411 | 0.011 | 0.042 | 0.029 | ||||
LMCI | 0.096 | <0.001 | 0.999 |
Adjusted P-values from Tukey's honest significant difference tests, controlling for family-wise error rate within each comparison block. CN, cognitively healthy elderly controls; EMCI/LMCI, early and late amnestic mild cognitive impairment; AD, Alzheimer's dementia.